Daily Briefing: Ancient Ground Squirrels Ate Like ‘Zombies of the Pleistocene’

Why It Matters

The BCG repurposing could reshape diabetes drug pipelines, AI pressure signals a looming shift in research funding, and the Prada‑Axiom partnership illustrates commercial opportunities in the burgeoning space‑wear market.

Key Takeaways

• Ancient ground squirrels consumed megafauna carcasses after hibernation, per 700k‑year DNA
• BCG vaccine cut insulin use, presented at ADA meeting June 7
• 1,900 scientists surveyed; 47% feel AI pressure, only 23% see positive impact
• Axiom Space partners with Prada on cooling garment for Artemis crew
• Peptide hype outpaces evidence; experts warn of safety gaps

Pulse Analysis

The unexpected diabetes benefit of the Bacillus Calmette‑Guérin (BCG) vaccine underscores the growing value of drug repurposing in biotech. By reducing insulin requirements, BCG could accelerate a new class of immunomodulatory therapies, prompting pharmaceutical firms to revisit legacy vaccines for metabolic disorders. Investors are watching regulatory pathways closely, as the vaccine already holds FDA approval for bladder cancer, potentially smoothing a faster market entry for diabetes indications.

Meanwhile, the AI sentiment poll reveals a cultural inflection point for scientific research. Nearly half of the 1,900 respondents feel compelled to use generative tools like ChatGPT, yet only a minority see tangible benefits. This disconnect creates a market for user‑friendly, domain‑specific AI platforms that address reproducibility and data security concerns. Funding agencies may soon prioritize proposals that demonstrate responsible AI integration, making early‑stage AI service providers attractive partners for research institutions.

The collaboration between Axiom Space and luxury fashion house Prada signals a maturation of the space‑wear ecosystem. Their liquid‑cooling and ventilation garment, slated for the Artemis crew, blends high‑performance textile engineering with brand prestige, opening revenue streams beyond traditional aerospace contracts. As commercial missions multiply, demand for astronaut apparel that balances safety, comfort, and marketability will rise, inviting further partnerships between aerospace firms and consumer‑focused designers. This trend points to a broader commercialization of low‑Earth orbit activities, where style and function converge to create new business models.